The main purpose of pharmacovigilance is to evaluate the benefit/ risk profile of the pharmacological therapy and to promote a more rational use of medicines in the population. 5% of all hospital admissions in Europe are due to Adverse Drug Reactions (ADRs). Pharmacovigilance aims to protect public health by reducing the impact of ADRs and optimizing the use of drugs. Rita Businaro, Assessing Pancreatic Cancer Risk Associated with Dipeptidyl Peptidase 4 Inhibitors: Data Mining of FDA Adverse Event Reporting System (FAERS).
Last date updated on June, 2014